Post Marketing Surveillance Study For Sayana®
NCT02104557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 362
Last updated 2021-06-10
Summary
Post Marketing Surveillance To Observe Safety And Efficacy Of Sayana® Used For Contraception And Management Of Endometriosis-Associated Pain
Conditions
- Product Surveillance, Postmarketing
Interventions
- OTHER
-
Non intervention
Non intervention
- OTHER
-
Non intervention
Non intervention
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 0 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-13
- Primary Completion
- 2020-06-05
- Completion
- 2020-06-05
Countries
- South Korea
Study Locations
More Related Trials
-
Regulatory Post Marketing Surveillance Study on YAZ
NCT00998257 ·Status: COMPLETED
-
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
NCT00185289 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
NCT01861886 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of an Oral Contraceptive in Healthy Females
NCT00206583 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
NCT00212342 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Oral Contraceptive Study
NCT00185484 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.
NCT00212277 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients
NCT03623126 ·Status: COMPLETED
-
Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914
NCT00456924 ·Status: COMPLETED ·Phase: PHASE2
-
Transdermal Contraceptive Patch - Endometrial Effects Study
NCT00896571 ·Status: COMPLETED ·Phase: PHASE2
-
Endometrial Safety Study
NCT00522873 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CDB-2914 for Emergency Contraception
NCT00411684 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT02021097 ·Status: UNKNOWN ·Phase: PHASE3
-
YAZ Post-marketing Surveillance in Japan
NCT01375998 ·Status: COMPLETED
-
A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
NCT00185419 ·Status: COMPLETED ·Phase: PHASE3
-
Visanne Study to Assess Safety in Adolescents
NCT01283724 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function
NCT01257984 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ
NCT00567164 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
NCT05282940 ·Status: COMPLETED ·Phase: PHASE1
-
Effect on Primary Dysmenorrhea
NCT00909857 ·Status: COMPLETED ·Phase: PHASE3
-
Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles
NCT00910637 ·Status: COMPLETED ·Phase: PHASE3
-
YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China
NCT02710708 ·Status: COMPLETED ·Phase: PHASE4
-
Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood
NCT02509767 ·Status: COMPLETED ·Phase: PHASE4
-
Mirena Post-marketing Surveillance in Japan
NCT01414140 ·Status: COMPLETED
-
Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.
NCT00195455 ·Status: COMPLETED ·Phase: PHASE4